Beranda › Kanker Ovarium › Georgia › Savannah
Uji klinis Kanker Ovarium di Savannah, GA
4 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Savannah (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Menerima pesertaFase 3
- Nancy N. & J.C. Lewis Cancer and Research Pavillion, Savannah
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Menerima peserta
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Menerima pesertaFase 3
- Nancy N. & J.C Lewis Cancer & Research Pavillion- St. Josephs/ Candler Health System, Savannah
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Savannah
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Studi lain di Savannah
- Kanker Payudara11 studi
- Kanker Paru Non-Sel Kecil10 studi
- Kanker Paru10 studi
- Kanker (semua jenis)6 studi
- Gangguan Depresi Mayor6 studi
- Diabetes Tipe 26 studi
- Melanoma5 studi
- PPOK5 studi
- Kanker Kolorektal4 studi
- Limfoma Non-Hodgkin3 studi
- Mania3 studi
- Leukemia Mieloid Akut3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.